Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
659 people get UTHR articles and Market Currents by email alert.
Get email alerts on UTHR »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
PR Newswire (Apr 25, 2013)
-
-
-
-
-
-
PR Newswire (Mar 25, 2013)
-
-
-
-
-
PR Newswire (Feb 26, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
United Therapeutics: Estimates On An UpswingZacks Investment Research • Mon, Oct 15, 2012 -
-
4 Reasons To Buy United TherapeuticsMarkus Aarnio • Tue, Jun 5, 2012
-
-
-
-
-
United Therapeutics Swings to Profit in Q4Proactive Investor • Wed, Feb 16, 2011 -
-
United Therapeutics Corporation Special CallWed, Aug 24, 2011
-
United Therapeutics Corporation Q4 2009 Earnings Call TranscriptTue, Feb 16, 2010
-
United Therapeutics Corp. Q2 2009 Earnings Call TranscriptFri, Jul 31, 2009
-
United Therapeutics Corporation Q4 2008 Earnings Call TranscriptTue, Feb 17, 2009
-
United Therapeutics Corporation Q2 2008 Earnings Call TranscriptThu, Jul 31, 2008
-
United Therapeutics Corp. Q1 2008 Earnings Call TranscriptFri, May 2, 2008
-
United Therapeutics Corp. Q4 2007 Earnings Call TranscriptTue, Feb 19, 2008
-
at MarketWatch.com (Apr 30, 2013)
-
PR Newswire (Apr 25, 2013)
-
PR Newswire (Mar 25, 2013)
-
PR Newswire (Feb 26, 2013)
-
PR Newswire (Feb 14, 2013)
-
PR Newswire (Feb 4, 2013)
-
PR Newswire (Nov 1, 2012)
-
at MarketWatch.com (Oct 24, 2012)
-
PR Newswire (Oct 23, 2012)
-
at CNBC.com (Oct 10, 2012)
-
at MarketWatch.com (Sep 25, 2012)
-
at Fox Business (Aug 15, 2012)
-
PR Newswire (Jul 26, 2012)
-
PR Newswire (Jun 27, 2012)
-
PR Newswire (Apr 26, 2012)
UTHR vs. ETF Alternatives
Company Description
We are a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions.
Our key therapeutic platforms are:
Prostacyclin Analogues, which are stable synthetic... More
-
- View all 0 replies
-
Red Acre Investments
Sent out Red Acre's weekly review last night $ZIOP, $RPRX, $AMRN, $VVUS, $APPA, $UTHR, $THLD signup at http://www.redacre.com to get it. - View all 3 replies
-
Red Acre Investments: Thx for the kind words - Happy Easter to you as well.
-
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Jim Van Meerten
$UTHR - 96% barchart technical buy signals - 9 new highs and up 8.52% in the last month - Relative Strength Index 71.79% - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
VFC's Stock House
Stock Watch Thursday - $BBRY, $AMRN, $GILD, $YMI, $TROV, $ONVO, $PFE, $UTHR - http://bit.ly/cAHZ42 - View all 0 replies
-
Jim Van Meerten
UTHR - 60% Barchart short term buy signal - $UTHR- 13 new highs in the last month - Relative Strength Index 61.64% - View all 0 replies
LATEST REPLIES
-
Red Acre Investments
Sent out Red Acre's weekly review last night $ZIOP, $RPRX, $AMRN, $VVUS, $APPA, $UTHR, $THLD signup at http://www.redacre.com to get it. - View all 3 replies
-
Red Acre Investments: Thx for the kind words - Happy Easter to you as well.
-
-
- View all 3 replies
-
Capitalist Bull: These are the stocks you want to pay attention to for possible setups in the near future.
-
Day Trader001: I get Volume alerts sent to me directly, I guess I just didn't get why you posted them. Thought I was missing something. Thanks
-
John Purdum
United Therapeutic Corp $UTHR chart shows high upside potential. Perfect timing of 50 Day/ 200 Day MA convergence. http://bit.ly/vH0Zfm - View all 2 replies
-
-
John Purdum: Previous earnings, forecasted earnings and sales. Somewhat difficult to calc for $UTHR because high earnings surprise 4 Q2, Q3.